Date Title Description PDF
07 Nov 2024 On P&L The Company releases the press release related to the first nine months 2024 financial results Download
07 Nov 2024 On P&L The Company releases the first nine months 2024 financial results presentation Download
24 Oct 2024 On corporate transactions ROVI completes the strategic review of its CDMO business Download
31 Jul 2024 On P&L The Company releases the press release related to the first half 2024 financial results Download
31 Jul 2024 On P&L The Company releases the first half 2024 financial results presentation Download

Pages

Date Title Description PDF
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download
21 Oct 2021 On business and financial situation The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). Download

Pages

Date Title Description PDF
27 Apr 2016 Información sobre resultados (2) The Company releases the press release related to the 2016 first quarter results Download
27 Apr 2016 Información sobre resultados The Company releases the press release related to the 2016 first quarter results Download
27 Apr 2016 Convocatorias y Acuerdos de Juntas y Asambleas Generales ROVI informs about the call for the General Shareholders Meeting Download
04 Apr 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2016 - correction Download
01 Apr 2016 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2016 Download

Pages